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Eukaryotic gene expression is regulated in the context of chromatin. Dynamic changes in post-translational
histone modification are thought to play key roles in fundamental cellular functions such as regulation of the
cell cycle, development, and differentiation. To elucidate the relationship between histone modifications and
cellular functions, it is important to monitor the dynamics of modifications in single living cells. A genetically
encoded probe called mintbody (modification-specific intracellular antibody), which is a single-chain variable
fragment tagged with a fluorescent protein, has been proposed as a useful visualization tool. However, the
efficacy of intracellular expression of antibody fragments has been limited, in part due to different
environmental conditions in the cytoplasm compared to the endoplasmic reticulum where secreted proteins
such as antibodies are folded. In this study, we have developed a new mintbody specific for histone H4 Lys20
monomethylation (H4K20me1). The specificity of the H4K20me1-mintbody in living cells was verified using
yeast mutants and mammalian cells in which this target modification was diminished. Expression of the
H4K20me1-mintbody allowed us to monitor the oscillation of H4K20me1 levels during the cell cycle. Moreover,
dosage-compensated X chromosomeswere visualized using the H4K20me1-mintbody inmouse and nematode
cells. Using X-ray crystallography and mutational analyses, we identified critical amino acids that contributed to
stabilization and/or proper folding of the mintbody. Taken together, these data provide important implications for
future studies aimed at developing functional intracellular antibodies. Specifically, the H4K20me1-mintbody
provides a powerful tool to track this particular histone modification in living cells and organisms.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Introduction
Histone proteins are subjected to a variety of post-
translational modifications that are thought to play
crucial roles in gene regulation and genome integrity
[1,2]. However, the precise role of specific histoneAuthors. Published by Elsevier Ltd. T
rg/licenses/by/4.0/).modifications in transcription, replication, repair, and
chromosome segregation remains to be elucidated. In
addition, it is unclear how histone modifications are
inherited or altered over time. Addressing the dynamic
regulation of histone modifications has been limited
because most studies conducted thus far have utilized
his is an open access article under the CC BY license
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3886 Live-Cell Imaging of H4K20 Monomethylationfixed cells, thus preventing single-cell assessment of
modification changes. To overcome the limitation of
using fixed cells, we have developed two live-cell
imaging systems based on the use of modification-
specific antibodies [3]. These approaches include Fab-
based live endogenous modification labeling (FabLEM
[4]) and a genetically encoded system using modifica-
tion-specific intracellular antibody probes (mintbodies
[5–7]). The latter approach is particularly useful for
investigations aimed at monitoring histone modifica-
tions in living animals.
Histone H4 Lys20 monomethylation (H4K20me1) is
a key histone modification that regulates DNA replica-
tion [8–10] and repair [11] as well as chromosome
compaction [12]. The level of H4K20me1 is regulated
by three methyltransferases, PR-Set7 [13–15],
Suv420H1, and Suv420H2 [16], and a demethylase,
PHF8 [17,18]. Chromatin immunoprecipitation com-
bined with deep sequencing (ChIP-seq) and immuno-
fluorescence analyses have shown that H4K20me1 is
generally distributed in euchromatin [16]. In addition,
H4K20me1 enrichment in inactivated X chromosomes
(Xi) and centromeres have also been reported
[16,19–21]. However, the spatiotemporal regulation of
H4K20me1 and its impact on DNAmetabolism remain
largely uncharacterized.
In this study, we report the generation of H4K20me1-
specific mintbody. X-ray crystallography and mutation
analyses identified key amino acids that improved
mintbody stability and/or folding. We demonstrate that
the H4K20me1-mintbody specifically recognizes the
target histone modification and is useful to monitor the
oscillations of H4K20me1 during the cell cycle and to
visualize dosage-compensated X chromosomes in
living mammalian cells and during Caenorhabditis
elegans development.Results
Generation and characterization of the
H4K20me1-specific mintbody
Togenerate a newmintbody specific forH4K20me1,
we cloned cDNA encoding variable regions of heavy
and light chains from 15F11/CMA421 hybridoma cellFig. 1. Generation of H4K20me1 specific mintbody. (a) Sch
heavy and light chains (VH and VL, respectively) were linked w
(b) The localization of H4K20me1-mintbodies in living cells. H4K
DNA was counterstained with Hoechst33342. H4K20me1-mi
bound to chromosomes during mitosis. (c–e) H4K20me1-min
mintbody (c and d) or GFP alone (e) were generated. WT, the
harbors a single H4 gene; H4.2 K20A, a strain that harbors K
H4K20me1, histone H4, and H4K20me1-mintbody (GFP) were
set9Δ and H4.2 K20A strains. (d and e) Living yeast cells expr
with Hoechst33342 and imaged using a fluorescence micros
Hoechst-positive chromatin regions in WT and H4.2 strains,
H4.2 K20A strains. (e) GFP distributed in the nucleus and cytline [22], and constructedmintbody expression vectors
by fusing the single-chain variable fragment (scFv) to
EGFP at the C-terminus (Fig. 1a). When expressed in
HeLa cells, H4K20me1-mintbody was diffuse in the
cytoplasm but concentrated in nuclei and chromo-
somes, where it co-localized with a DNA staining
Hoechst33342 dye (Fig. 1b). This suggests that the
probe binds to nuclear targets in living cells, as
designed.
Todetermine if theH4K20me1-mintbody specifically
recognizes H4K20me1, like its parental IgG [22], we
performed both in vitro and in vivo analyses. We
assessed binding in vitro using recombinant histone
H4 proteins that harbor methylation-mimic modifica-
tions [22] as well as synthetic peptides arrays. When
these were incubated with bacterially expressed and
purified H4K20me1-scFv (Supplementary Fig. S1a),
only H4 harboring monomethylation-mimic modifica-
tions and synthetic H4K20me1 peptides were bound
by the scFv (Supplementary Fig. S1b–d). These results
suggest that the specificity of the original IgG was well
retained in the scFv format.
We next evaluated the specificity of H4K20me1-
mintbody in living cells using fission yeast Schizo-
saccharomyces pombe, which can be genetically
manipulated to delete the targetmodification. Targeting
of the H4K20me1-mintbody to the crescent-shaped
chromatin compartment in the nucleus can also
be assessed readily in S. pombe (Supplementary
Fig. S2a) [23,24]. We generated yeast strains express-
ing H4K20me1-mintbody in the wild type and set9Δ
background. As Set9 is the sole H4K20 methyltrans-
ferase in S. pombe [25], no H4K20me1 was expected
in set9Δ strains. Indeed, immunofluorescence and
immunoblotting using the specific antibody showed
no H4K20me1 in set9Δ strains (Fig. 1c and Supple-
mentary Fig. S2b). Note that similar results were
obtainedusingH4K20me1-scFv, insteadof the specific
IgG, which further validates that the scFv retained the
original specificity (Supplementary Fig. S2c and d).
To assess H4K20me1-mintbody localization in the
wild type and set9Δ background strains, growing yeast
cells were incubated with Hoechst33342 for DNA
labeling [26]. In the wild-type background, the
H4K20me1-mintbody was concentrated in the chro-
matin domain, as represented byHoechst staining, and
excluded from the nucleolar domain in the nucleusematic structure of mintbody. Antibody variable regions of
ith a flexible linker and fused to EGFP at the C-terminus.
20me1-mintbody was stably expressed in HeLa cells, and
ntbody was concentrated in nuclei during interphase and
tbody in S. pombe. Yeast strains expressing H4K20me1-
wild type; set9Δ, set9-deleted strain; H4.2 wt, a strain that
20A substitution in the single H4.2 gene. (c) The levels of
assessed byWestern blotting. H4K20me1 was depleted in
essing H4K20me1-mintbody (d) and GFP (e) were stained
cope. (d) The H4K20me1-mintbody was concentrated in
and diffuse in the nucleus and cytoplasm in set9Δ and
oplasm in all strains. Scale bars represent 10 μm.
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contrast, in the set9Δ strain, the H4K20me1-mintbody
diffused throughout the cell and the concentration in the
chromatin domain was substantially reduced. Although(a)
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3888 Live-Cell Imaging of H4K20 MonomethylationTo further assess the specificity of the mintbody,
we generated a strain that harbors a single H4 gene
by deleting two out of three H4 genes in S. pombe
(H4.2 wt), and another strain that harbors a single
mutant H4 gene in which lysine 20 is substituted with
alanine (H4.2 K20A). As expected, H4K20me1-
mintbody was enriched in the chromatin domain of
the H4.2 wt, but not in the H4.2 K20A strain (Fig. 2d
and e). These results indicate that H4K20 methyla-
tion is required for H4K20me1-mintbody's chromatin
targeting.
To examine if H4K20me1-mintbody specifically rec-
ognizesH4K20me1overH4K20me2andH4K20me3,
we used a mammalian cell line harboring multiple
H4K20 methyl transferases with selective activities
(Fig. 2a); PR-Set7/SET8/SETD8/KMT5A is known to
monomethylate unmodified H4K20, and SUV420H1/
KMT5B and SUV420H2/KMT5C mediate further
methylation (to me2 and me3) of H4K20me1 [16]. A
demethylase PHF8 is also known to demethylate
H4K20me1 [17,18]. We anticipated that over-
expression of these enzymes would alter the balance
among different methylation states in living cells. To
screen the effect of overexpression onH4K20methyl-
ation, HeLa cells were transfected with HaloTag-
fusion enzymes and then fixed and stained with the
specific antibodies directed against H4K20me1,
H4K20me2, andH4K20me3.HaloTag-fusionenzymes
were labeled with tetramethylrhodamin-conjugated
HaloTag ligand (TMR Halo ligand), and DNA was
counterstained with Hoechst33342. After collecting
fluorescence images, the intensities of antibody and
TMR Halo ligand in single-cell nuclei were measured
and plotted. Among the three methylation and one
demethylation enzymes we examined, Halo-
SUV420H1 affected H4K20me1 levels the most
drastically (Fig. 2b–d and Supplementary Fig. S3b).
In cells expressingHalo-SUV420H1,H4K20me1 levels
were substantially decreased, and reciprocally
H4K20me3 was increased, which is consistent with
the action of SUV420H1 [16]; H4K20me2 remained
unchanged except in the highest expressing cells
(Fig. 2c). We then overexpressed Halo-SUV420H1
in HeLa cells stably expressing H4K20me1-mintbodyFig. 2. The nuclear concentration of H4K20me1-mintbod
(a) H4K20 methylation states and responsible enzymes. Th
PR-Set7, SUV420H1/2, and PHF8. (b–d) Overexpression
transiently expressing Halo-SUV420H1 were fixed and stai
directed against H4K20me1, H4K20me2, or H4K20me3, tetra
sections were collected using a confocal microscope, and fluo
and Halo-SUV420H1 in single cells were quantified. (b) Ex
expressing SUV420H1 (arrowhead). (c and d) Intensity plots
(x-axis) and H4K20 methylation (y-axis) in a single-cell nucleu
cells. See Supplementary Fig. S3 for the effects of other enz
H4K20me1-mintbody. Halo-SUV420H1 was transiently expr
mintbody. The mintbody was more diffuse in the cytoplasm in
cytoplasm intensity ratios in single cells were plotted (right g
Halo-SUV420H1 expression. The scale bars represent 10 μmto evaluate if the probe can monitor the decrease
in living cells.Wehadpreviously shown that changes in
the global acetylation level can be monitored by the
nuclear enrichment of H3K9ac-mintbody [5]; H3K9ac-
mintbody becomes more concentrated in the nucleus
when acetylation levels increase. If H4K20me1-
mintbody selectively binds to H4K20me1, changes in
H4K20me1 level should also affect the nuclear
concentration of H4K20me1-mintbody.
A day after transfection of the Halo-SUV420H1 ex-
pression vector, cells were incubated with Halo TMR
ligand and Hoechst33342, and fluorescence images
were collected for quantifying the nuclear and
cytoplasmic intensities of H4K20me1-mintbody and
the nuclear intensity of Halo-SUV420H1 (Fig. 2e). The
nucleus to cytoplasm intensity ratios of H4K20me1-
mintbody in SUV420H1-expressing cells were indeed
lower compared to untransfected cells, and more
effects were seen in higher expressing cells (Fig. 2e,
right), similar to the H4K20me1 antibody staining
(Fig. 2c, left). This result indicates that H4K20me1-
mintbody can be used in living cells to selectively
monitor H4K20me1, as opposed to H4K20me2 or
H4K20me3.
To further evaluate the specific binding of
H4K20me1-mintbody to H4K20me1 in HeLa cells,
a simple co-localization analysis was employed by
comparing the distribution of H4K20me1-mintbody
with those of different modifications, including
H4K20me1, H4K20me2, H4K20me3, H3K4me1,
H3K9me1, and H3K27me1 (as detected with specific
antibodies). After collecting confocal fluorescence
images of H4K20me1 and each of the antibodies, we
performed a co-localization analysis to obtain co-
localization plots and correlation coefficients. As
expected, H4K20me1-mintbody was most highly cor-
related with H4K20me1, even though H4K20me1-
mintbody signals had higher background than the
antibody stains, probably due to the presence of
unbound mintbody (Supplementary Fig. S4). Taken
together, these data support the view that H4K20me1-
mintbody specifically binds to H4K20me1 in living
cells and is useful as a probe to monitor the level and
localization of H4K20me1.y depends on H4K20 monomethylation in living cells.
e level of H4K20 monomethylation can be controlled by
of SUV420H1 decreased H4K20me1 level. HeLa cells
ned with Alexa Fluor 488-conjugated mouse antibodies
methylrhodamine Halo ligand, and Hoechst33342. Optical
rescent intensities of H4K20 mono-, di-, or tri-methylation
ample images. H4K20me1 signal was weaker in a cell
. Each dot represents the intensities of Halo-SUV420H1
s. (c) Halo-SUV420H1 transfected cells. (d) Untransfected
ymes. (e) H4K20me1 levels in living cells monitored with
essed in HeLa cells that stably expressed H4K20me1-
the cell that expressed SUV420H1 (arrowhead). Nuclear/
raph). Nuclear/cytoplasm ratios decreased depending on
.
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the cell cycle
To investigate whether the H4K20me1-mintbody
could be used as a live-cell probe without disturbing
cell function, we compared cell growth and cell cycle
progression in HeLa cells that stably expressedH4K20 H4K20
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3891Live-Cell Imaging of H4K20 MonomethylationWe then investigated whether H4K20me1-
mintbody can monitor the oscillations of H4K20me1
levels during the cell cycle in living cells. A number of
studies have reported that H4K20me1 increases
during lateG2 andM, and decreases after cell division
and throughout G1 and S [9,15,27,28]. We confirmed
this oscillation in HeLa cells expressing mCherry-
tagged proliferating cell nuclear antigen (PCNA), a
marker of DNA replication factories [29], by time-
lapse imaging followed by immunofluorescence with
the H4K20me1-specific antibody (Fig. 3c and Sup-
plementary Fig. S5a). This trend remained the same
after normalization usingDNAdensity (Hoechst33342
intensity) (Fig. 3d).We thenusedHeLacells that stably
express both H4K20me1-mintbody and mCherry-
PCNA. After time-lapse imaging to identify the cell
cycle position, the nuclear and cytoplasmic intensities
of H4K20me1-mintbody at the final image were
measured to obtain the nuclear/cytoplasm ratio. This
ratio is expected to reflect H4K20me1 levels, as
shown before. The nuclear/cytoplasm ratio increased
in G2 and M compared to G1 and S (Fig. 3e and
Supplementary Fig. S5b). A few examples of cells
imaged for a long period (over 45 h) are shown in
Fig. 3f andSupplementary Fig. S6. These live-cell data
are qualitatively in good agreement with the previous
studies that utilized Western blotting and mass
spectrometric approaches [27,28]. This result
demonstrates that the H4K20me1-mintbody enables
monitoring of changes in H4K20me1 levels in living
cells.We noticed, however, that the nuclear/cytoplasm
ratio during interphase should not be directly com-
pared with the chromosome/cytoplasm ratio during M
phase. Although the nuclear intensity of H4K20me1-
mintbody peaked inM phase, it dropped to a minimum
when normalized with Hoechst33342 intensity due to
chromosome condensation (Supplementary Figs. S7
and S8). In fact, the nuclear intensity includes both the
bound and free H4K20me1-mintbody molecules, andFig. 3. Tracking the level of H4K20me1 during the ce
H4K20me1-mintbody and the parental cells. Cells were plate
number was counted by resuspending into the original volum
from three independent experiments are plotted with the st
proliferated similarly to control HeLa cells. (b) Cell cycle analys
incorporated EdU and DNA content (Hoechst33342 staining
(means with the standard deviations; n = 3) are shown. No sig
between the control andmintbody-expressing cells (p values = 0
Student's t test). (c) H4K20me1 levels during the cell cycle. HeLa
identify the cell cycle position, fixed, and stained with anti-H4K20
cells at different cell cycle positions are shown (meanswith the st
for details. (d) H4K20me1 levels normalizedwith intensities of Ho
divided by Hoechst intensity to compensate for chromatin conde
during the cell cycle. HeLa cells that stably express H4K20me
identify the cell cycle position, and nuclear/cytoplasm ratio was
(n = 9–13). See Supplementary Fig. S5b for details. (f) Represen
Elapsed times are indicated above the images (hh:mm). The ce
shown below. The scale bar represents 10 μm. (g) The fluoresc
and the nuclear/cytoplasm ratios are plotted. Intensities during m
cannot be directly compared with those during interphase (seefree molecules disperse into the cytoplasm after the
nuclear membrane breaks down; a similar minimiza-
tion in Fab-probe nuclear/cytoplasm ratio during M
phase was shown previously [30]. Therefore, a careful
interpretation is needed when cells undergo dynamic
changes in shape.
Visualization of Xi using the H4K20me1-mintbody
in living cells
H4K20me1 has been described as one of the
epigenetic marks associated with the Xi in cultured
cells, in addition to H3 trimethylated at lysine 27
(H3K27me3) [16,19,20]. To investigate whether Xi
can be visualized with the H4K20me1-mintbody, we
used mouse embryonal carcinoma cell line MC12
that harbors Xi fused to an autosome fragment [31].
Immunofluorescence using fixed cells revealed that
when the H4K20me1-mintbody was expressed in
MC12 cells, the probe was enriched on Xi together
with H3K27me3 and H4K20me1 (detected by the
specific antibodies) (Fig. 4a). Using metaphase
chromosome spreads, we also observed that the
H4K20me1-mintbody was enriched on the arm of Xi,
but not on Hoechst-dense pericentromeric major
satellite regions (Fig. 4b). Time-lapse imaging of
H4K20me1-mintbody indeed allowed us to visualize in
single cells the dynamic behavior of Xi during the cell
cycle, including mitosis (Fig. 4c). Enrichment of the
H4K20me1-mintbody on Xi was also observed in
hTERT-RPE1 cells, a human pseudo-diploid female
cell line immortalized with telomerase (Supplementary
Fig. S9). In addition, accumulation of H4K20me1 on
centromere was visualized using the H4K20me1-
mintbody (Supplementary Fig. S9), as previously
reported [21].
Making use of the detectability of Xi by the
H4K20me1-mintbody, we monitored the exact timing
of Xi replication by time-lapse imaging using MC12ll cycle. (a) Growth curves of HeLa cells expressing
d on a dish (2 × 105 cells/ml; 2 ml) at time 0, and the cell
e every 12 h. Mean cell concentrations at each time point
andard deviation. Cells expressing H4K20me1-mintbody
is. Cell cycle phase was defined based on the intensity of
). Example profiles and the fractions of different phases
nificant difference in each cell cycle phase was observed
.227, 0.256, and 0.392, for G1, S, and G2/M, respectively, by
cells expressing mCherry-PCNA were imaged overnight to
me1 antibody (CMA421). Intensities of the antibody in single
andard deviations, n = 10–15). SeeSupplementary Fig. S5a
echst33342 during the cell cycle. The antibody intensity was
nsation. (e) Nuclear/cytoplasm ratio of H4K20me1-mintbody
1-mintbody and mCherry-PCNA were imaged overnight to
measured. Means with the standard deviations are plotted
tative images of H4K20me1-mintbody andmCherry-PCNA.
ll cycle phase, judged by the nuclear distribution of PCNA, is
ent intensities in the nucleus and cytoplasm were measured
itotic phase are indicated as dashed gray line as the values
Supplementary Figs. S7 and S8).
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(hh:mm). (d) Representative images of MC12 cells expressing both H4K20me1-mintbody andmCherry-PCNA. The timing of
Xi replication was judged by the co-localization of H4K20me1-mintbody and mCherry-PCNA. Arrowheads indicate Xi, which
replicated in the middle of S phase (Mid-S). (e) The timing and length of Xi replication in S phase. The period of PCNA foci
appearance (“S phase,” red bars) and the timing of co-localization with Xi foci (“Xi replication,” yellow bars) are shown (nine
individual cells and the averages with the standard deviations). The scale bars represent 10 μm.
3892 Live-Cell Imaging of H4K20 Monomethylationcells that stably express both the H4K20me1-
mintbody and mCherry-PCNA (Fig. 4d). In early S
phase, numerous PCNA foci were observed in
euchromatic regions and were excluded from Xi.
As cells progressed through mid-S phase, PCNAfoci appeared preferentially around the nuclear
periphery and were also enriched on Xi. A few
hours later, we observed the appearance of larger
PCNA foci and their separation from Xi. Replication
of Xi often began at precisely the middle of S phase
3893Live-Cell Imaging of H4K20 Monomethylationand was complete in 2–3 h, allowing ~2 additional
hours to complete S phase (Fig. 4e).
Visualization of Xi during early development in
C. elegans
Finally, to demonstrate that the H4K20me1-
mintbody can also be utilized in living multicellular
organisms, we used C. elegans as a model. In XX
hermaphrodite worms, X-linked gene expression is
twofold repressed by a dosage compensation
complex to equalize gene dosage with XO males
[32]. H4K20me1has been reported tobeenriched inX
chromosomes in hermaphrodites and to participate in
the repression [33]. We generated a transgenic
nematode line that expressed the H4K20me1-
mintbody. The worms developed normally and were
fertile, indicating that the mintbody expression did not
have inhibitory effects. We found that the H4K20me1-
mintbody was present in nuclei with subtle concen-
tration patterns in the 120-cell and Bean stages
(Fig. 5; 1 and 2). After the Comma stage, however,
two bright foci were clearly observed in each nucleus
(Fig. 5; 3–6). The transition in H4K20me1 localization
during development has been demonstrated in a
previous study using an H4K20me1-specific antibody
[33]. It is therefore likely that the change in mintbody
localization is not due to differences in accessibility of
themintbody to the chromosomes, but instead reflects
true localization of H4K20me1. This result demon-
strates the utility of our newH4K20me1probeasa tool
to visualize changes in chromosome structure and
dosage-compensated X chromosomes inC. elegans.1
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H4K20me1-specific mintbody
Previous studies [34–36] have demonstrated that
small differences in amino acid sequence can affect
the folding and/or stability of functional scFv expressed
in living cells. In addition to the clone 15F11/CMA421
used to generate the H4K20me1-mintbody, we also
obtained from the same immunized mouse two other
hybridoma clones, 12C8 and 22G3. The deduced
amino acid sequences of VH andVLwere highly similar
among these clones, and the diversity was probably
due to somatic hypermutation (Supplementary
Fig. S10), as previously reported [5]. When expressed
inHeLa cells in scFv-GFP form, these proteins failed to
accumulate in nuclei (Fig. 6a and Supplementary
Fig. S12a), suggesting that these two scFv-GFP
proteins are less stable and/or more prone to aggre-
gate than the H4K20me1-mintbody derived from
15F11/CMA421.
To identify structure–function relationships that
impact intracellular scFv expression, we performed
mutational and structural analyses. H4K20me1-
mintbody and 12C8 scFv-GFP differed in only five
amino acids, four of which were located in the frame-
work regions (FRs; dark blue and pink in Fig. 6b) and
the remaining one in a complementarity determining
region (light blue in Fig. 6b). We then investigated the
functional impact of these amino acids in living cells by
introducing point mutations and assessing effects on
chromatin binding, or nucleoplasmic enrichment. We
replaced each of the five 12C8-specific amino acids
with the corresponding residues present in the 15F115
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Fig. 6. Mutational and structural analysis of H4K20me1-mintbody. (a) Intracellular localization of H4K20me1-mintbody.
H4K20me1-mintbody (derived from 15F11) and 12C8-scFv-EGFP were expressed in HeLa cells. 12C8-scFv-EGFP was
not functional in the cells. (b) The position of amino acid substitutions between 15F11 and 12C8. (c) The localization of
12C8-scFv-EGFP mutants. Each of the five amino acids in 12C8 was changed to the corresponding amino acid in 15F11
(R32S, M95I, G99A, D105H, and A150 T) and expressed in HeLa cells. The nuclear localization of G99A mutant suggests
that this mutation significantly improved the stability and/or folding in cells. (d) The localization of H4K20me1-mintbody
mutants. Either I95M or A99G mutation alone did not abolish the nuclear localization, although the nuclear signal was
relatively weakened. The combinatorial mutation was not concentrated in nuclei. (e) The crystal structure of 15F11-scFv at
1.94 Å resolution. VH and VL are shown in light blue and pink, respectively. The amino acids that differ in 12C8 are
indicated in yellow. Space-filling models of two important residues (I95 and A99; letters shown in red) are blown-up to the
side. The oxygen and nitrogen atoms are colored in red and dark blue. The scale bars represent 10 μm.
3894 Live-Cell Imaging of H4K20 Monomethylationtype. When expressed in HeLa cells, only the 12C8
G99A mutant exhibited nucleoplasmic concentration
in the transfected cells (Fig. 6c), pointing to a key role
for A99 in the function of 15F11. However, a reciprocal
15F11 mutant (A99G) was still in the nucleoplasm,
although it diffused more into the cytoplasm (Fig. 6d).
We then generated double mutants that combined
A99G and I95M mutations (I95M–A99G) and found
that this 15F11 mutant was no longer concentrated in
the nucleoplasm (Fig. 6d). Thus, both I95 and A99 are
critical for the intracellular function of the 15F11-
derived H4K20me1-mintbody.While the I95 andA99 residues are clearly important
for the robust stability and/or folding of theH4K20me1-
specific mintbody in living cells, they may differentially
affect binding to H4K20me1. Therefore, we measured
the binding affinities of different H4K20me1-specific
antibodies in their IgG and scFv forms, using surface
plasmon resonance (SPR). In their native IgG form,
15F11 and 12C8 showed similar profiles and affinities
(52 and 33 pM, respectively, by two-state fitting),
whereas 22G3 was much weaker (15 nM) (Supple-
mentary Fig. S11). To purify scFv versions of each,
His6-tagged constructs were expressed in Escherichia
3895Live-Cell Imaging of H4K20 Monomethylationcoli. Although a substantial fraction of 15F11-scFv
was recovered in the cytosolic extract,most 12C8-scFv
and 22G3-scFv remained in the insoluble pellet
(Supplementary Fig. S12b), suggesting that 12C8
and 22G3 are more prone to aggregate than 15F11
in bacteria, as in mammalian cells. We then purified
scFvs from pellets by denaturation and renaturation.
15F11 and 12C8 were successfully purified (Supple-
mentary Fig. S12c), although 22G3 aggregated during
renaturation. According to SPR, the affinities of 15F11
and 12C8 in scFv forms were again similar to each
other (250 nM and 100 nM, respectively, by two-state
fitting), although they were more than 3 orders of
magnitude lower than those of the counterpart IgG
forms. These results are consistent with the view that
thedifferencebetween15F11and12C8 is their stability
and/or folding inside cells rather than their affinity to
target modifications.
To investigate the role of these amino acids in the
structure of H4K20me1-mintbody, we determined the
crystal structure of recombinant 15F11 scFv, which
were purified from the soluble fraction of E. coli lysate
(Supplementary Fig. S1a). The crystal structure of the
scFv was solved at a resolution of 1.94 Å (Fig. 6e).
Structural analysis revealed that both I95 and A99
are located inside the immunoglobulin fold. I95 is in
hydrophobic contactwith Y97 and is located nearQ41,
G116, T117, and T118 (Fig. 6e). Interestingly, the side
chain of I95 is exposed to the solvent. In contrast, A99
is buried in the hydrophobic core composed of V39,
F110, and W113 (Fig. 6e). When A99 is replaced with
glycine, this hydrophobic interaction is likely loosened
due to absence of the side-chain methyl-group
(Supplementary Fig. S13). These observations sug-
gest that A99 plays a key role in stabilizing the
H4K20me1-mintbody.Discussion
In this study, we developed an H4K20me1-
mintbody, a new genetically encoded antibody-based
probe specific for the detection of H4K20me1. From
various in vitro and in vivo analyses,we concluded that
the H4K20me1-scFv and H4K20me1-mintbody retain
the original IgG's specificity to H4K20me1. The
H4K20me1-mintbody allowed us to monitor changes
in the level of H4K20me1 during the cell cycle and
localization of Xi. Furthermore, dosage-compensated
X chromosomes were observed in living transgenic
nematodes that express the H4K20me1-mintbody.
The structure of H4K20me1-specific variable
fragments
Cytoplasmic expression of antibody fragments has
been challenging because the cytoplasmic environ-
ment differs from the endoplasmic reticulum, where
antibodies are naturally folded and processed. Thisdifference can cause low solubility and instability, often
leading to aggregation [37]. In the present study,
H4K20me1-mintbody (derived from15F11) functioned
properly in the cytoplasm, but 12C8-scFv-GFP and
22G3-scFv-GFP did not. The heavy-chain variable
regions of the H4K20me1-specific antibodies were
very similar to the human VH3 type shown to be
thermodynamically stable and less prone to aggrega-
tion by the systematic studies of human combinatorial
antibody libraries [34,38,39]. Importantly, key amino
acids present in the framework regions were con-
served, including E8 (corresponding to amino acid H6
in the Kabat numbering system and H6 in the AHo
numbering system [34,40], written as “E8(H6/6)”),
F31(H29/31), V39(H37/44), R69(H66/77), D92(H85/
100), and T117(H107/143) (Supplementary Fig. S10).
In addition, R100(H94/108) and D111(H101/137) at
the edges of complementarity determining region 3,
which canmake a salt bridge [34,37], were conserved.
These features were common to all three H4K20me1-
specific antibody clones, suggesting that these
proteins had high potential as functional intracellular
antibodies [36]. However, conservation of framework
regions was not sufficient, as only 15F11 was
functional in living cells. Crystallographic and muta-
tional analyses revealed that A99(H93/97) is critical in
the formation of a hydrophobic core with V39(H37/44),
F110(H100e/119), and W113(H103/139). Replace-
ment of G99(H93/97) with alanine in 12C8 likely
strengthened hydrophobic interactions and greatly
improved functionality, as judged by thenucleoplasmic
accumulation of theG99Amutant. A structuremodel of
A99G reveals that hydrophobic contacts with the
residue at position 99(H93/97) are indeed greatly
reduced (Supplementary Fig. S13). Alanine at the
H93/97 position is conserved in human VH3, and the
hydrophobic core involving this alanine may be
important for the general stability of the scFv structure.
However, substitution of A99(H93/97) with glycine in
15F11 did not completely prevent nucleoplasmic
accumulation, although the signal was relatively
weak and diffused. Hence, in addition to A99(H93/
97), 15F11 functionalitywas assisted by I95(H89/103),
which associates with Q41(H39/45), Y97(H91/105),
G116(H106/142), T117(H107/143), and T118(H108/
144). Although Q41(H39/45), Y97(H91/105),
G116(H106/142), and T117(H107/143) are conserved
amino acids in human VH3, I95(H89/103) and
T118(H108/144) are not. The I95(H89/103)-mediated
intramolecular hydrophobic interaction may have a
supporting function in the mintbody stability in living
cells. It would be interesting to investigate how these
variations affect the stability and folding of VH3-type
scFv.
An overall negative charge at cytoplasmic pH and
low hydrophilicity has been proposed to improve the
solubility of intracellular antibodies [41]. However, the
net charge and hydropathicity (GRAVY score [41]) of
H4K20me1-scFvs are 0, −0.389, and −0.1 and
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22G3, respectively. Thus, variations in charge and
hydrophilicity do not account for differences in the
solubility we observed in the three H4K20me1-scFv-
GFPs. Instead, we found that the appropriate forma-
tion of hydrophobic cores involvingA99(H93/97) plays
a pivotal role in mintbody folding and proper cellular
function. The structure–function relationships hereby
analyzed provide useful information on further devel-
opment of intracellular antibodies.
Live-cell imaging using the H4K20me1-mintbody
In this study, we demonstrated that Xi can be
visualized in living cells using our newly developed
H4K20me1-mintbody. This strategy, combined with
mCherry-PCNA imaging, allowed precise determina-
tion of Xi replication timing at the single-cell level. In
mouse MC12 cells, Xi replication took place in mid-S
phase, a period during which facultative heterochro-
matin was replicated, in agreement with a previous
study in mouse C2C12 cells [42]. It has recently been
suggested that replication of Xi is rapid, random, and
less organized than that of actively transcribed
genome regions [43], and that this feature may
account for increased mutation rates. Enrichment of
H4K20me1 on Xi may represent involvement of this
modification in DNA damage repair. Future studies
using H4K20me1-mintbody combined with probes
targeting DNA damage repair proteins and their
modifications (e.g., gamma-H2A.X) may reveal the
relationship between H4K20me1 and DNA damage
repair on Xi during DNA replication. Utilization of the
H4K20me1-mintbody in differentiating cells is also
anticipated to help visualize the process of Xi
formation.
Two mintbodies have been developed to date,
including the H4K20me1-mintbody described here
and a previously reported H3K9ac-speific mintbody
[5,6]. A recent in vivo study in transgenic frogs using
the H3K9ac-mintbody has detected changes in
acetylation during notochord regeneration [7], thus
demonstrating the high potential of this genetically
encoded system. Further development of additional
mintbodies directed against diverse histone post-
translational modifications will facilitate the identifica-
tion of regulatory mechanisms that control epigenetic
modifications in vivo.Materials and Methods
Plasmid construction
To generate the H4K20me1-mintbody expression
vectors, cDNAs encoding variable regions of heavy
and light chains (VH and VL) of specific antibodies
against H4K20me1 (CMA421/15F11, 12C8, and22G3) were cloned as previously described [5]. VH
and VL cDNAs were connected into a single chain
through a linker encoding 3× GGGGS. The resulting
DNA was subcloned into the pEGFP-N2 vector
(Clontech). Nucleotide sequence data of scFvs
(CMA421/15F11, 12C8, and 22G3) are available in
several public databases (DDBJ/EMBL/GenBank)
under the accession numbers LC129890, LC129891,
and LC129892, respectively. Amino acid substitution
mutants were generated using a Quick Change kit
(Stratagene). For expression of enzymes that con-
trol H4K20 methylation, Halo-PHF8, Halo-PR-Set7
(SETD8), Halo-SUV420H1, and Halo-SUV420H2
(Kazusa DNA Research Institute; FlexiHaloTag clone
FHC01149, FHC06789, FHC01413, and FHC26822)
were used. For Figs. 3 and 4, a pMX-puro-based
expression vector carrying mCherry-PCNA [44] was
co-transfected with the H4K20me1-mintbody expres-
sion vector. For analyzing enrichment of H4K20me1-
mintbody on centromeres, hTERT-RPE1 cells were
co-transfected with expression vectors for CENP-A-
TagRFP [45] and H4K20me1-mintbody.
Histone modification antibodies
Mouse monoclonal antibodies anti-H4K20me1
(CMA421), anti-H4K20me2 (CMA422), anti-
H4K20me3 (CMA423) [22], anti-H3K4me1 (CMA302)
[46], anti-H3K9me1 (CMA316) [11], anti-H3K27me1
(4C4), and anti-H3K27me3 (CMA323) [4] were used.
For immunofluorescence, antibodies were labeled with
Alexa Fluor 488 (Thermo Fisher Scientific), Cy3 (GE
Healthcare), or Cy5 (GE Healthcare). For H3K9me1
(CMA316), unlabeled IgG and Cy5-conjugated goat
anti-mouse Fc secondary antibodies (Jackson Immu-
noresearch) were used.
Protein purification and biochemical analysis
The DNA fragments encoding 15F11-scFv, 12C8-
scFv, and 22G3-scFv were cloned into the pET15b
vector (Novagen), which includes a His6 tag at
the N-terminus. His6-15F11-scFv was expressed in
E. coli BL21 (DE3) at 25 °C. Bacterial cells producing
His6-scFvswere harvested by centrifugation and then
disrupted by sonication in 50 mM Tris–HCl (pH 7.5)
buffer, containing 500 mMNaCl, 1 mMphenylmethyl-
sulfonyl fluoride (PMSF), and 10% glycerol. After
centrifugation, precipitates were denatured in 50 mM
Tris–HCl (pH 8.0) buffer, containing 500 mM NaCl,
7 M Gdn–HCl, and 5% glycerol. After centrifugation,
the supernatantsweremixedwith theNi-NTAagarose
(Qiagen) by rotating at 4 °C for 1 h. The beads were
packed into an Econo-column (Bio-Rad) and washed
with a 50-column volume of 50 mM Tris–HCl (pH 8.0)
buffer, containing 500 mMNaCl, 5 mM imidazole, 6 M
urea, 10% glycerol, and 2 mM 2-mercaptoethanol.
His6-scFvs were eluted with a 50-column volume liner
gradient of 5–500 mM imidazole in 50 mM Tris–HCl
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10% glycerol, and 2 mM 2-mercaptoethanol. The
His6-scFvs were refolded during the dialysis against
20 mM Tris–HCl (pH 7.5) buffer, containing 1 mM
EDTA, 200 mM NaCl, 2 mM 2-mercaptoethanol, and
10% glycerol at 4 °C. The resulting His6-scFv proteins
were further purified by gel filtration column chroma-
tography (Superdex 75 HiLoad 16/60 prep grade; GE
Healthcare) and elutedwith phosphate-buffered saline
(PBS). The purity was checked by 16% SDS-PAGE
(Supplementary Fig. S12c).
For preparation of 15F11-scFv for Western blot
analysis, histone modification arrays, immunofluores-
cence of yeast cells, and crystallization, theE. coli cells
producing His6-15F11-scFv were disrupted by sonica-
tion in 50 mM Tris–HCl (pH 7.5) buffer, containing
500 mM NaCl, 1 mM PMSF, and 10% glycerol. After
removing cell debris by centrifugation, the supernatant
was collected and mixed with Ni-NTA agarose by
rotating at 4 °C for 30 min. The beads were washed
with 50-column volume of 50 mM Tris–HCl (pH 7.5)
buffer, containing 500 mM NaCl, 5 mM imidazole,
1 mM PMSF, 10% glycerol, 0.01% Triton X-100, and
2 mM 2-mercaptoethanol. His6-15F11-scFv was
eluted with a 50-column volume liner gradient of 5–
500 mM imidazole in 50 mM Tris–HCl (pH 7.5) buffer,
containing 500 mM NaCl, 1 mM PMSF, 10% glycerol,
0.01% Triton X-100, and 2 mM 2-mercaptoethanol.
The His6 tag peptide was cleaved by thrombin
protease (GE Healthcare) during the dialysis against
20 mM Tris–HCl (pH 7.5) buffer, containing 1 mM
EDTA, 200 mM NaCl, 2 mM 2-mercaptoethanol, and
10%glycerol at 4 °C. The resulting 15F11-scFv protein
was further purified by gel filtration column chromatog-
raphy (Superdex 75 HiLoad 26/60 prep grade;
GE Healthcare) and eluted with PBS. The purity
was checked by 16% SDS-PAGE (Supplementary
Fig. S1a).
ForWestern blot analysis (Supplementary Fig. S1b),
recombinant histone H4 proteins harboring mono-
methylation-, dimethylation-, and trimethylation-mimic
K20 (Active motif; 10–20 ng/lane for antibodies,
100 ng/lane for scFv) were separated on 15%
SDS-polyacrylamide gels. Proteins were transferred
onto a polyvinylidene difluoridemembranes in 100 mM
Tris–HCl, 192 mM glycine, and 5% methanol, using a
semidry transfer system. After blocking with Blocking
One (Nacalai Tesque) for 20 min, membranes were
incubated in H4K20me1-specific (15F11/CMA421;
1 μg/ml), H4K20me2-specific (CMA422; 1 μg/ml),
and H4K20me3-specific (CMA423; 0.2 μg/ml) mouse
monoclonal antibodies [22] for 1 h at room tempera-
ture, and then in horseradish peroxidase (HRP)-
conjugated goat anti-mouse IgG (Jackson Immunor-
esearch) for 1 h at room temperature. When probed
with the 15F11-scFv, membranes were incubated in
5 μg/ml scFv at 4 °C overnight, and then in
HRP-conjugated goat anti-mouse IgG. For Supple-
mentary Fig. S1c and d, a peptide array (AbSuranceComplete Core Histone Antibody Specificity Array;
Millipore) was incubated in 15F11-scFv (2 μg/ml)
overnight and then in HRP-conjugated goat
anti-mouse IgG. Signals were detected using an
enhanced chemiluminescent system (Immunostar
LD; Wako Purechemicals).
SPR signals (Supplementary Figs. S11 and S12d)
weremeasured using aBiacoreX100 (GEHealthcare),
as described previously [5]. H4K20me1 synthetic
peptide (GKGGAKRHR(me1-K)VLRDNIQGI) (Sigma-
Aldrich) was conjugated to a CM5 sensor chip (GE
Healthcare) (for scFv, 87.1 RU; for IgG, 16.9 RU) by
amine coupling in PBS containing 0.005%Tween20 as
a running buffer. For the binding assay, single cycle
kinetics was performed, and different concentrations of
antibodies (for scFv: 15.625, 31.25, 62.5, 125, and
250 nM; for IgG: 3.125, 6.25, 12.5, 25, and 50 nM)
were successively injected at 30 μl/min. The resulting
curves were analyzed with a two-state reaction model.
Crystallization and structure determination
Purified 15F11-scFv was concentrated to 30 mg/
ml, dialyzed against 20 mM Bis–Tris–HCl (pH 6.0)
buffer, containing 100 mM NaCl, and crystallized
using the hanging drop vapor diffusion method. One
microliter of purified 15F11-scFv was mixed with an
equal volume of reservoir buffer (100 mM sodium
acetate [pH 5.2], 7% poly-γ-glutamic acid polymer,
and 12% PEG2000) at 20 °C and crystal growth was
observed in 2 weeks. Crystals were soaked into the
cryoprotectant solution (100 mM sodium acetate
[pH 5.2] and 30% PEG300) and flash-cooled in a
stream of N2 gas (100 K). The dataset was collected
at the BL-1A, BL-5A, and BL-17A beamlines in the
Photon Factory (KEK) and the BL41XU beamline in
SPring-8. Diffraction data were indexed, integrated,
and scaled using the HKL2000 program [47]. The
structure of 15F11-scFv was solved by the molecular
replacement method, using the Phaser program [48]
and the PDB entry 2GHW as the search model [49].
Manual model building was performed using the
COOT program [50]. Refinements of the models
were performed using the PHENIX program [51].
The final structure contains no Ramachandran
outliers, assessed by the MolProbity program
(Supplementary Table I) [52]. All protein structure
figures were prepared with PyMOL (Schrödinger†).
The structure of 15F11-scFv was deposited into the
Protein Data Bank (PDB ID: 5B3N).
Cell culture
Cells were routinely grown in Dulbecco's modified
Eagle's medium (Nacalai Tesque) with supplements
(L-glutamine/penicillin/streptomycin [Sigma-Aldrich]
and 10% fetal calf serum) at 37 °C under 5% CO2
atmosphere. Mouse embryonal carcinoma cell line
MC12 was kindly provided by Dr. Nobuo Takagi [31].
3898 Live-Cell Imaging of H4K20 MonomethylationTransfection of plasmid DNA was performed using
Fugene HD (Promega), and cells stably expressing
mintbody were selected in 1 mg/ml G418 (Nacalai
Tesque). For live-cell imaging, cells were grown on a
35-mm glass bottom dish (Mat-Tek) or a 24-well glass
bottom plate (Iwaki), and the medium was replaced
with FluoroBrite Dulbecco's modified Eagle's medium
(Thermo Fisher Scientific) containing supplements.
Growth curve and cell cycle profile
HeLa cells stably expressing H4K20me1-
mintbody and the parental cells were plated on a
six-well dish (3 wells each) at a concentration of
2 × 105 cells/ml (2 ml). Cells were harvested in the
original volume every 12 h and cell concentration
was counted using an EVE automatic cell counter
(Nano EnTek). Cell concentrations from 3 wells were
averaged to obtain the result of a single experiment.
Three independent experiment were performed to
obtain the mean and the standard deviation. For cell
cycle profiling, cells grown on a glass bottom dish
were incubated in 10 μM EdU (Thermo Fisher
Scientific) for 30 min, fixed with 4% formaldehyde
(Electron Microscopy Sciences) in 250 mM Hepes–
NaOH (pH 7.4; Wako Purechemicals) containing
0.1% Triton X-100 for 5 min, and permeabilized with
1% Triton X-100 in PBS for 20 min at room temper-
ature. EdU was labeled with Alexa Fluor 647 azide for
30 min, using Click-iT EdU Imaging Kit (Thermo
Fisher Scientific), and DNA was stained with 1 μg/ml
Hoechst33342 in PBS for 20 min, before imaging
using a wide-field fluorescence microscope (Ti-E;
Nikon; operated by NIS-elements software), equipped
with an EM-CCD (iXON+ DU897 X-3019, Andor), a
40× Plan Apo (NA 0.95) lens. Hoechst33342 and
Alexa Fluor 647 were detected using DAPI-1160A
(Semrock; Ex FF01-387/11; DM FF02-447/60; Em
FF409-Di02) and Cy5-4040A (Semrock; Ex FF02-
628/40; DM FF660-Di02; Em FF01-692/40) filter sets.
The nuclear intensities of fluorescence signals were
automatically quantified using NIS-elements analysis
software (over 1000 cells per experiment). DNA
content in each cell was obtained by multiplying
mean Hoechst intensity with ROI area. Cell cycle
phaseswere defined according to theDNAcontent and
Cy5 intensity (G1, Cy5 b 200 and DNA b 250,000; S
phase, Cy5 N 200; G2/M, Cy5 b 200 and DNA N
250,000). The average cell cycle fractions (with the
standard deviations) were obtained from three inde-
pendent experiments.
Immunofluorescence
Cells were fixed with 4% formaldehyde (Electron
Microscopy Sciences) in 250 mM Hepes–NaOH
(pH 7.4; Wako Purechemicals) containing 0.1%
Triton X-100 for 5 min at room temperature, perme-
abilized with 1% Triton X-100 in PBS for 20 min atroom temperature. After blockingwith BlockingOne-P
(Nacalai Tesque) for 20 min at room temperature,
cells were incubated with 2 μg/ml fluorescence dye
(Alexa Fluor 488, Cy3, or Cy5)-conjugated mouse
monoclonal antibody for 2 h at room temperature.
After washing with PBS three times, cells were
incubated with 0.25–1 μg/ml Hoechst33342 for
20 min. After washing with PBS three times, fluores-
cence images were collected. For Supplementary
Fig. S5a, a glass bottom dish with a grid (Matsunami)
was used to match cells in time-lapse and immunoflu-
orescence images. For Fig. 2b–d and Supplementary
Fig. S3, 24 h after transfection with HaloTag ex-
pression vectors, cells were stained with 2–4 μg/ml
antibodies, 0.1 μM HaloTag tetramethylrhodamine
ligand (Promega), and 0.25 μg/ml Hoechst33342 for
2 h at room temperature.
Metaphase chromosome spreads
MC12 cells stably expressing the H4K20me1-
mintbody were incubated with colcemid (50 ng/ml;
Nacalai Tesque) for 1.5 h, and mitotic cells were
collected by pipetting and brief centrifugation. Mitotic
cells were swelled using hypotonic buffer (75 mM
KCl) for 10 min at room temperature. Hepes–NaOH
(Wako Purechemicals; 250 mM final concentration,
pH 7.4) and formaldehyde (Electron Microscopy
Sciences; 0.4% final concentration) were added just
before the cytospin (WESCOR; 1000 rpm, 2 min).
Chromosome spreads were fixed for 5 min at room
temperature, and then stained with 20 ng/ml
Hoechst33342 in PBS for 10 min at room temperature.
Microscopy for mammalian cells
Fluorescence imageswere collected using confocal
microscopes: an FV1000 (Olympus; operated by the
built-in FV1000 software FLUOVIEW ver.4.2), a Ti-E
(Nikon; operated by NIS-elements software) with a
spinning disk (CSU-W1; Yokogawa) and an EM-CCD
camera (iXON3 DU888 X-8465, Andor), or an IX-71
(Olympus) equipped with a spinning disk (CSU-X1;
Yokogawa) and an EM-CCD camera (iXON3
DU897E-CS0-#BV-Y, Andor). Live-cell imaging was
performed with a heated stage (Tokai Hit) and a CO2-
control system (Tokken). For Figs. 1b and 2e, and
Supplementary Figs. S5b and S7b, 1 μg/ml
Hoechst33342was added to cells 1 h before imaging.
Acquisition parameters are shown in Supplementary
Table II. Quantification of fluorescence intensities was
performed using NIS-elements analysis software
(Nikon). For immunofluorescence images, nuclei
were automatically defined by thresholding and
fluorescence intensities in individual nuclei were
quantified. For images of H4K20me1-mintbody, the
ROI areas of the nuclei and cytoplasm were manually
defined and the fluorescence intensities were quan-
tified. The net intensity was obtained by background
3899Live-Cell Imaging of H4K20 Monomethylationsubtraction. To compare the nuclear enrichment of
H4K20me1-mintbody in different cells, the nuclear/
cytoplasm ratio was frequently used. The nuclear/
cytoplasm ratio could be over-influenced by a
cytoplasmic intensity that is too low and variable, but
the actual intensity counts a few hundred after
background subtraction (in a 14-bit scale) and the
deviation is comparable to or lower than the nuclear
intensity. The statistics of the nuclear and cytoplasmic
intensities used for Fig. 3e are shown inSupplementary
Fig. S14, as an example. For Supplementary Fig. S4,
co-localization analysis was performed using NIS-
elements analysis software (Nikon).
Fission yeast experiments
An S. pombe strain (HA1039-3D, h− lys1–131) was
used as wild type. For set9+ gene disruption, a gene
disruption fragment was amplified by PCR using a
G418-resistant gene cassette, and used for transfor-
mation of the wild type strain [53]. An H4K20A mutant
strain was constructed according to a previous study
with some modifications [54]. Briefly, a pair of histone
H4.2/H3.2 genes (hhf2+–hht2+) was cloned into a
plasmid DNA, and an H4.2 K20A mutation was
introduced by PCR-mediated site-directed mutagen-
esis to convert the 20th codon AAG to GCT. The
genomic hhf2+–hht2+ genewas disrupted by replace-
ment with the ura4+ marker gene, and the ura4+
marker gene was further replaced with the mutant
gene. H4.2 K20A mutant cells were selected in a
medium containing 5-fluoroorotic acid, which is toxic
for ura4+ cells. To disrupt the other two histone H4/H3
genes, H4.1/H3.1 and H4.3/H3.3 were replaced with
G418-resistant and nourseothricin-resistant genes
[55]. YES and EMM2 were used as complete and
minimal media, respectively [56]. To express GFP-
fused 15F11-scFv in S. pombe cells, the scFv-coding
sequence was inserted downstream of the β-tubulin
(nda3+) gene promoter and fused to GFPs65t. The
resulting fusion gene was then integrated into the
genomic lys1 locus. ForWestern blot analyses, whole
cell extracts were prepared according to the following
procedure. S. pombe cells were grown until they
reached the log phase and further incubated in the
presence of 1 mM PMSF for 10 min. 5 × 107 cells
were then harvested and resuspended in 800 μl of
ice-cold water. The cell suspension was mixed with
150 μl of 2 M NaOH, incubated for 10 min on ice,
added with 150 μl of 55% (w/v) trichloroacetic acid,
mixed, and incubated for a further 10 min on ice.
After centrifugation at 10,000 rpm for 2 min at 4 °C
using a microcentrifuge, the pellet was washed
with cold acetone and then resuspended in SDS-
polyacrylamide gel sample buffer (60 mM Tris–HCl
[pH 6.8], 2% SDS, 100 mM DTT, 10% glycerol, and
bromophenol blue). A volume equivalent to 2 × 106
cells from each sample was separated on 15% SDS-
polyacrylamide gels. Proteins were transferred ontopolyvinylidene difluoride membranes in 100 mM Tris–
HCl, 192 mM glycine, and 5% methanol, using a
semidry transfer system. Membranes were incubated
in H4K20me1-specific (15F11/CMA421; 1 μg/ml)
and pan-H4 (CMA400; 0.1 μg/ml) mouse mono-
clonal antibodies [22], and a GFP-specific rabbit
polyclonal antibody (Rockland Immunochemicals
Inc.; 0.25 μg/ml), and then in HRP-conjugated goat
anti-mouse or anti-rabbit IgG (GE Healthcare). For
immunoblot experiments with the 15F11-scFv, mem-
branes were incubated in 20 μg/ml scFv overnight at
4 °C, and then in HRP-conjugated goat anti-mouse
IgG.
Live-cell imaging was performed at 26 °C using a
DeltaVision fluorescence microscopy system (Applied
Precision), which is built on a wide-field fluorescence
microscope IX71 (Olympus), equipped with a 60×
PlanApoN (NA 1.40) oil-immersion lens and a Cool-
SNAP HQ2 CCD (Photometrics). Cells were immobi-
lized as described previously [57]. Images were
deconvolved using SoftWoRx software.
Fluorescence microscopy using anti-H4K20me1
antibody (CMA421) and 15F11-scFv was done as
follows. Cells grown in complete medium were
harvested and fixed using 4% formaldehyde in
0.1 M phosphate buffer (pH 7.2) for 10 min at room
temperature. After cell wall digestion by 0.6 mg/ml
zymolyase 100T (Nacalai tesque) in PEMS buffer
(100 mM Pipes, 1 mM EGTA, 1 mM magnesium
chloride and 1.2 M sorbitol) for 70 min at 36 °C, cells
were permeabilized by 1% Triton X-100 in PEMS for
2 min at room temperature. Blockingwasdonewith 1%
bovine serum albumin for 30 min at room temperature.
For staining with CMA421, cells were incubated with
1 μg/ml antibody for 1 h at room temperature. For
staining with 15F11-scFv, cells were incubated with
100 μg/ml scFv overnight at 4 °C, although the same
result was obtained by incubation with 20 μg/ml scFv.
An Alexa488-conjugated goat anti-mouse antibody
(GE Healthcare) was used as a secondary antibody.
Chromatin was stainedwith a 0.2 μg/ml 4′,6-diamidino-
2-phenylindole. Cells were observed using DeltaVision
fluorescence microscopy system (Applied Precision).
Expression and imaging of the
H4K20me1-mintbody in the C. elegans embryos
TheDNAsequenceof 15F11-scFvwassynthesized,
taking into consideration codon usage in C. elegans
(GeneArt Gene Synthesis; Thermo Fisher Scientific).
To generate an expression vector compatible with
Mos1-mediated single copy insertion (MosSCI), the
following four segments were joined using a Gateway
Compatible Plasmid Toolkit and Multisite Gateway
Technology (Thermo Fisher Scientific), as previously
described [58]. The segments joined were as follows:
(i) mex-5 5′ untranslated region, (ii) codon-optimized
15F11-scFv sequence, (iii) mex-5 3′ untranslated
region following to gfp F64LS65T, and (iv) MosSCI
3900 Live-Cell Imaging of H4K20 Monomethylationintegration site followed by unc-119+ rescue marker.
Using theMosSCI technology, the resulting vector was
integrated into the unc-119 (ed3)mutant genome. The
integrated lines were screened according to previously
described protocols [59]. Strains were maintained
at 22 °C or 26 °C. For microscopic imaging, adult
hermaphrodites were dissected in M9 buffer and
released embryoswere transferred onto a 2% agarose
pad mounted on a glass slide and covered with
a coverslip. Fluorescence signals of H4K20me1-
mintbody were collected at room temperature using a
microlens-enhanced spinning-disk confocal unit
(CSU-X1; Yokogawa) mounted on an inverted micro-
scope (IX71; Olympus) equipped with a 100× UPlan-
SApo (NA 1.40) lens and an EM-CCD camera (iXon;
Andor), and controlled byMetaMorph imaging software
(ver 7.7.10.0; Molecular Devices). z-Stacks of 12
planes with 2-μm intervals were collected using a
488-nm laser line (100-ms exposure). Stacked images,
which were composed by maximum projection of
seven to nine serial z-planes, and extracted single
section images (Fig. 5) were generated using Meta-
Morph imaging software (ver 7.7.10.0).
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